5 results
8-K
EX-99.1
OCEL
Organicell Regenerative Medicine, Inc.
6 Jun 23
Private And Confidential. © 2023 Organicell Regenerative Medicine, Inc. All rights reserved. Investor Presentation June 2023 1
4:53pm
Cosmetics 2. PPX Ƴ ▪ Next - generation therapeutic for musculoskeletal conditions like knee osteoarthritis and tendon injuries ▪ Exosomes are derived
8-K
EX-10.1
OCEL
Organicell Regenerative Medicine, Inc.
30 Apr 20
Entry into a Material Definitive Agreement
1:40pm
character, name, or description including reasonable attorney fees, brought on account of any injuries or damage, or loss (real or alleged) received under
S-1/A
OCEL
Organicell Regenerative Medicine, Inc.
11 Oct 12
IPO registration (amended)
12:00am
may become subject to legal actions based on a claim that our products are defective in workmanship or have caused personal or other injuries. We
S-1
OCEL
Organicell Regenerative Medicine, Inc.
4 Sep 12
IPO registration
12:00am
are defective in workmanship or have caused personal or other injuries. We currently do not maintain liability insurance and we may not be able to obtain
- Prev
- 1
- Next